Skip to main content
×
Home
    • Aa
    • Aa

Fluoxetine for the treatment of SSRI discontinuation syndrome

  • Franco Benazzi (a1)
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Fluoxetine for the treatment of SSRI discontinuation syndrome
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Fluoxetine for the treatment of SSRI discontinuation syndrome
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Fluoxetine for the treatment of SSRI discontinuation syndrome
      Available formats
      ×
Copyright
Corresponding author
Address for correspondence: F. Benazzi, M.D., Ph.D., Hecker Psychiatry Research Center – Department of Psychiatry, NHS, Forli, via Pozzetto 17 Cervia RA 48015, Italy. Tel.: +39 335 6191 852Fax: +39 054 330 069E-mail: FrancoBenazzi@FBenazzi.it
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

F Benazzi (1998b). SSRI discontinuation syndrome treated with fluoxetine. International Journal of Geriatric Psychiatry 13, 421422.

F Benazzi (1999b). Selective serotonin reuptake inhibitor discontinuation syndrome: putative mechanisms and prevention strategies. Canadian Journal of Psychiatry 44, 9596.

GA Fava , M Bernardi , E Tomba , C Rafanelli (2007). Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia. International Journal of Neuropsychopharmacology 10, 835838.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The International Journal of Neuropsychopharmacology
  • ISSN: 1461-1457
  • EISSN: 1469-5111
  • URL: /core/journals/the-international-journal-of-neuropsychopharmacology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×